CXCL10 and dermatomyositis: In this study, galectin‐9 and CXCL10 were validated as strong, reliable, and sensitive biomarkers for disease activity in juvenile DM, and both were identified as promising biomarkers both in adult patients with DM and in adult patients with NSM.